Tenon Medical Files 8-K on Shareholder Vote Matters
Ticker: TNONW · Form: 8-K · Filed: Sep 23, 2025 · CIK: 1560293
| Field | Detail |
|---|---|
| Company | Tenon Medical, Inc. (TNONW) |
| Form Type | 8-K |
| Filed Date | Sep 23, 2025 |
| Risk Level | medium |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $1.25 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: TNON
TL;DR
Tenon Medical is asking shareholders to vote on key company matters.
AI Summary
On September 18, 2025, Tenon Medical, Inc. filed an 8-K report detailing a submission of matters to a vote of its security holders. The filing indicates that the company is seeking approval from its shareholders on certain corporate actions.
Why It Matters
This filing signals that Tenon Medical is proceeding with important corporate decisions that require shareholder approval, potentially impacting the company's future direction and shareholder rights.
Risk Assessment
Risk Level: medium — Shareholder votes can lead to significant changes in corporate governance or strategy, introducing uncertainty.
Key Players & Entities
- Tenon Medical, Inc. (company) — Registrant
- September 18, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41364 (identifier) — Commission File Number
- 45-5574718 (identifier) — IRS Employer Identification No.
- 104 Cooper Court (address) — Principal executive offices
- Los Gatos, CA 95032 (address) — Principal executive offices
- (408) 649-5760 (phone_number) — Registrant's telephone number
FAQ
What specific matters are being submitted for a vote of Tenon Medical's security holders?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not specify the exact matters in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 18, 2025.
What is the Commission File Number for Tenon Medical, Inc.?
The Commission File Number is 001-41364.
Where are Tenon Medical, Inc.'s principal executive offices located?
Tenon Medical, Inc.'s principal executive offices are located at 104 Cooper Court, Los Gatos, CA 95032.
What is the IRS Employer Identification Number for Tenon Medical, Inc.?
The IRS Employer Identification Number for Tenon Medical, Inc. is 45-5574718.
Filing Stats: 1,154 words · 5 min read · ~4 pages · Grade level 12.5 · Accepted 2025-09-23 16:30:24
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Mar
- $1.25 — k, in each case at an exercise price of $1.25 per share. The Series C-1 Warrants will
Filing Documents
- ea0258406-8k_tenon.htm (8-K) — 40KB
- 0001213900-25-090627.txt ( ) — 245KB
- tnon-20250918.xsd (EX-101.SCH) — 4KB
- tnon-20250918_def.xml (EX-101.DEF) — 26KB
- tnon-20250918_lab.xml (EX-101.LAB) — 36KB
- tnon-20250918_pre.xml (EX-101.PRE) — 25KB
- ea0258406-8k_tenon_htm.xml (XML) — 5KB
07 Submission
Item 5.07 Submission of Matters to a Vote of Security Holders. Tenon Medical, Inc. (the "Company") held its 2025 Annual Meeting of Stockholders (the "Annual Meeting") virtually on September 18, 2025, after prior sessions on July 23, 2025 and August 20, 2025 were adjourned due to the absence of a quorum. The Annual Meeting was originally scheduled with a record date of June 6, 2025. Following the August 20 adjournment, the Board of Directors established a new record date of August 22, 2025, which superseded the prior record date. As of August 22, 2025, the Company had 8,602,992 shares of common stock outstanding, each entitled to one vote per share, and 204,159 shares of Series A Preferred Stock and 86,454 shares of Series B Preferred Stock outstanding, each entitled to 1.25 votes per share, together constituting the Company's outstanding voting securities. Proxies previously submitted remained valid unless revoked or resubmitted. At the reconvened meeting on September 18, 2025, the holders of 4,635,903 shares of common stock were represented in person or by proxy, constituting a quorum under Delaware law and the Company's Bylaws. The matters submitted to a vote of stockholders and the final voting results were as follows: 1. Election of the seven (7) nominees to the Board of Directors of the Company : Name Votes For Withheld Broker Non-Votes Richard Ferrari 2,609,108 64,237 1,962,558 Steven Foster 2,611,010 62,335 1,962,558 Richard Ginn 2,608,772 64,573 1,962,558 Stephen Hochschuler, MD 2,485,488 187,857 1,962,558 Ivan Howard 2,486,810 186,535 1,962,558 Kristine Jacques 2,609,719 63,626 1,962,558 Robert Weigle 2,487,743 185,602 1,962,558 Each director nominee was elected to serve as a director until the Company's 2026 annual meeting of stockholders, or until such person's successor is duly elected and qualified, or until such person's earlier resignation, death or removal. Due to the fact that directors are elected by
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: September 23, 2025 Tenon Medical, Inc. By: /s/ Steven M. Foster Name: Steven M. Foster Title: Chief Executive Officer and President 3